We are live on ! Find out more
PVMCV

Polaris Venture Management Co V Portfolio holdings

AUM $14.1M
1-Year Est. Return 121.41%
This Fund
S&P 500
This Quarter Est. Return
-11.5%
1 Year Est. Return
+121.41%
3 Year Est. Return
+281.18%
5 Year Est. Return
+1,023.01%
10 Year Est. Return
–
AUM
$113M
AUM Growth
-$2.91M
Cap. Flow
+$24M
Cap. Flow %
21.13%
Top 10 Hldgs %
100%
Holding
10
New
1
Increased
–
Reduced
4
Closed
–

Top Buys

Rank Stock Value
1
XFOR icon
X4 Pharmaceuticals
XFOR
+$26.3M

Top Sells

Rank Stock Value
1
PULM icon
Pulmatrix
PULM
+$1.38M
2
KALA icon
KALA BIO
KALA
+$608K
3
RNAC icon
Cartesian Therapeutics
RNAC
+$302K
4
DARE icon
Dare Bioscience
DARE
+$6.71K

Sector Composition

Rank Sector Weight
1 Healthcare 93.19%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KALA icon
1
KALA BIO
KALA
$13.6M
$34.3M 30.28%
744
-13
-2% -$608K
XFOR icon
2
X4 Pharmaceuticals
XFOR
$377M
$23.8M 21.03%
+10,383
New +$26.3M
RNAC icon
3
Cartesian Therapeutics
RNAC
$227M
$15.8M 13.9%
53,560
-691
-1% -$302K
FATE icon
4
Fate Therapeutics
FATE
$293M
$15.1M 13.32%
2,473,186
– –
TTOO
5
DELISTED
T2 Biosystems, Inc
TTOO
$7.73M 6.81%
375
– –
ATYR
6
aTyr Pharma
ATYR
$47.1M
$6.4M 5.64%
130,571
– –
PULM icon
7
Pulmatrix
PULM
$6.21M
$3.94M 3.48%
13,982
-4,058
-22% -$1.38M
TRVN
8
DELISTED
Trevena, Inc.
TRVN
$3.29M 2.9%
3,286
– –
GNCA
9
DELISTED
Genocea Biosciences, Inc.
GNCA
$2.28M 2.01%
246,076
– –
DARE icon
10
Dare Bioscience
DARE
$18.6M
$706K 0.62%
27,187
-209
-0.8% -$6.71K

Similar funds

IFC
Intact Financial Corporation Toronto, Ontario, Canada $14M AUM
AG
Ashmore Group London, United Kingdom $16.3M AUM 57.83% 1-Year Est. Return
RCM
Raging Capital Management Rocky Hill, New Jersey $18.2M AUM 17.75% 1-Year Est. Return
IR
Invictus RG Hamilton, Bermuda $8.9M AUM 56.32% 1-Year Est. Return
CCM
Copernicus Capital Management San Francisco, California $8.26M AUM 37.91% 1-Year Est. Return
EIP
Edgbaston Investment Partners $20.3M AUM 35.98% 1-Year Est. Return
AAM
Areion Asset Management Hong Kong $7.82M AUM 16% 1-Year Est. Return
OEP
Ocean Endowment Partners Chicago, Illinois $20.6M AUM 27.63% 1-Year Est. Return

Polaris Venture Management Co V's Q4 2017 Portfolio in Review

As of Q4 2017, Polaris Venture Management Co V held 10 positions worth $113M, down 2.5% from $116M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Polaris Venture Management Co V deployed $24M of net new capital in Q4 2017, opening 1 new position. Its largest new stake was X4 Pharmaceuticals: 10,383 shares worth $23.8M.

By sector, the portfolio is most concentrated in Healthcare at 93% of assets, down from 93% a quarter earlier.

On the sell side, the largest reduction was Pulmatrix, an estimated $1.38M trimmed.

  • Polaris Venture Management Co V's largest Q4 2017 buy was X4 Pharmaceuticals: 10,383 shares worth $23.8M.
  • Polaris Venture Management Co V's biggest Q4 2017 reduction was Pulmatrix, cutting an estimated $1.38M.
  • Polaris Venture Management Co V's ten largest holdings make up 100% of its $113M portfolio in Q4 2017.
  • Polaris Venture Management Co V opened 1 new position and closed 0 in Q4 2017.
  • Polaris Venture Management Co V's portfolio value fell 2.5% quarter-over-quarter to $113M.

Based on Polaris Venture Management Co V's 13F filing for Q4 2017, filed 8 Feb 2018.